Stockreport

CNS Pharmaceuticals Announces Contract with International GMP Manufacturer for Production of Berubicin

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF HOUSTON, Jan. 14, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of nove [Read more]